SICHENZIA ROSS FRIEDMAN FERENCE LLP
                  1065 AVENUE OF THE AMERICAS NEW YORK NY 10018
               TEL 212 930 9700 FAX 212 930 9725 WEB WWW.SRFF.COM

November 4, 2005

Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C.  20549
Attention: Derek Swanson, Esq.
           Mail Stop 3561

      Re:   Walker Financial Corporation (the "Company")
            Amendment No. 3 to Form SB-2
            File No. 333-122776

            Form 10-KSB for the year ended December 31, 2003
            Forms 10-QSB for the quarter ended September 30, 2004
            File No. 0-28173

Dear Mr. Swanson:

On behalf of the Company,  we are hereby enclosing two copies of Amendment No. 3
(the  "Amendment")  to the  Company's  registration  statement on Form SB-2 (the
"Registration  Statement").  One of the copies has been  marked to show  changes
from  Amendment No. 2 to the  Registration  Statement  ("Amendment  No. 2"). The
Registration  Statement  was filed on February 11, 2005. By letter dated October
28, 2005,  the staff of the  Securities  and Exchange  Commission  (the "Staff")
issued  comments on  Amendment  No. 2 and the Form  10-QSB for the three  months
ended  September 30, 2004 and the three months ended  September,  2004,  and the
Form 10-KSB for the years ended  December 31, 2004 and 2003  (together,  the "34
Act  Reports ")  (Commission  File No.  0-13215).  Following  are the  Company's
responses  to the Staff's  comments.  For ease of  reference,  each  response is
preceded by the Staff's comment.

General

      1.    Please note that  specific  references to page numbers where changes
            were made in response to each comment greatly expedite our review of
            your amended filings.

            We have included page references in our responses in accordance with
            the Staff's comment.

Management's Discussion and Analysis and Plan of Operations, page 11

Overview, page 11




      2.    We note that the  overview  section  was not  revised to provide the
            disclosure requested by our prior comment 8. Please revise to expand
            the Overview section of MD&A to more thoroughly  discuss the matters
            referenced  in that prior  comment,  such as your default  under the
            promissory   notes  indenture  and  your  ability  to  service  your
            outstanding indebtedness.

            The Company has made  revisions  to the  Registration  Statement  in
            accordance with the Staff's comment. See page 11 of the Amendment.

Critical Accounting Policies, page 12

      3.    Please expand upon your  discussion of  accounting  for  stock-based
            compensation,  as requested by our prior  comment 12, to analyze how
            your use of the Black-Scholes valuation method impacts the resulting
            compensation expense recognized in your Statement of Operations. For
            example,   expand  to  quantify   or  explain   how  the   resulting
            compensation expense would differ if an alternative valuation method
            were employed. In addition, as noted in our prior comment 11, please
            discuss the material  implications of uncertainties  associated with
            the methods,  assumptions,  and estimates underlying your accounting
            measurements.  As currently drafted,  your discussion simply recites
            the mechanics of each accounting method.

            The Company has made  revisions  to the  Registration  Statement  in
            accordance with the Staff's comment. See page 13 of the Amendment.

Plan of Operations, page 21

      4.    Revise  to  give   specific   examples  of  how  you  will   finance
            acquisitions  of other  companies,  in light  of your  $1.3  million
            working capital deficit and your  expectations that you will receive
            $1 million under the equity line  arrangement  (all of which will go
            towards  satisfying  your  working  capital  deficit).  In addition,
            please  explain  how you will  finance  your  planned  $1 million in
            expenditures  over the next 12 months to expand  your  business,  as
            disclosed on page 20, when you will be required to use the entire $1
            million you will receive from Fusion Capital to satisfy your current
            liabilities.

            The Company has made  revisions  to the  Registration  Statement  in
            accordance with the Staff's comment.  See pages 18, 19 and 20 of the
            Amendment.

      5.    We note your disclosure that the company will be able to control the
            timing of any sales of shares under the equity line arrangement with
            Fusion Capital. We note, however, that there are often conditions to
            an underwriter  having to receive shares under a typical equity line
            arrangement  which could affect the company's ability to put shares.
            For example,  underwriters  typically  are not obligated to purchase
            shares from a company if the purchase would cause the underwriter to
            own more than 9.9% of the company's  outstanding stock. We note that
            Fusion Capital currently  beneficially owns  approximately 6% of the
            company's stock. After accounting for the commitment fee and signing
            fee shares, Fusion Capital could own 9.9% of the company's stock. In
            light of this,  revise the  disclosure to highlight the  uncertainty
            that the company  will  receive $1 million  under the equity line in
            the next 12 months  and  clarify  that  there are  likely to be some
            conditions to Fusion  Capital's  obligation to purchase shares under
            the equity line.

            The Company has made  revisions  to the  Registration  Statement  in
            accordance with the Staff's comment.  See pages 18, 19 and 20 of the
            Amendment.


                                       2


Selling Stockholders, page 43

      6.    Please  revise the Selling  Stockholders  section to  disclose  that
            Moschetta Poiyvion,  Allan Levine, and Michael Schumacher each is an
            affiliate of a  broker-dealer.  In addition,  revise to confirm,  if
            true, that each of those selling  shareholders  (1) purchased in the
            ordinary  course of business and, (2) at the time of the purchase of
            the  securities  to be  resold,  the  seller  had no  agreements  or
            understandings,   directly  or   indirectly,   with  any  person  to
            distribute  the  securities.  The Company has made  revisions to the
            Registration  Statement in accordance with the Staff's comment.  See
            page 39 of the Amendment.


Recent Sales of Unregistered Securities, page II-2

      7.    We note your response to our prior comment 35. Since your  agreement
            with  Vantage  Group  requires  the company to issue  "unrestricted"
            shares to Vantage,  tell us in your response letter why "restricted"
            securities  issued pursuant to Section 4(2) of the Securities Act of
            1933 satisfy this condition of the agreement.

            The Company  advises the Staff  supplementally  that the  disclosure
            under Item 26  regarding  the  issuance of shares to the Vantage was
            made in error.  These  shares were issued under the  Company's  2002
            Equity Incentive Plan that were registered under a Form S-8 that was
            filed on April 21, 2004.  Accordingly,  the Company has deleted this
            disclosure. See page II-3 of the Amendment.

Forms  10-KSB for the fiscal year ended  December 31, 2004 and December 31, 2003
and Forms  10-QSB for the  quarter  ended June 30,  2005,  March 31,  2005,  and
September 30, 2004

      8.    Please  amend these  documents to comply with all of our comments as
            applicable to your Forms 10-KSI3 for the fiscal years ended December
            31, 2003 and December  31,  2004,  and Forms 10-QSB for the quarters
            ended September 30, 2004, March 31, 2005, and June 30, 2005.

            The  Company is in the  process of  revising  the 34 Act Reports and
            will be filing them as soon as practicable.

      9.    Please note that all of our prior comments relating to the Form SB-2
            that are  applicable to your  periodic  reports must be reflected in
            amendments to your periodic  reports prior to the  effectiveness  of
            the Form SB-2.

            The Company  understands  that all of the Staff's prior  comments on
            the  Registration  Statement  that are  applicable  to its  periodic
            reports must be reflected in  amendments  to such  periodic  reports
            prior to the effectiveness of the Registration Statement.

Please contact the  undersigned at  212-981-6766  with any questions or comments
you may have with respect to the foregoing.

                                                Very truly yours,

                                                /s/ Louis A. Brilleman
                                                ----------------------
                                                Louis A. Brilleman


                                       3